These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10897422)

  • 1. Structure activity relationship study of polymyxin B nonapeptide.
    Tsubery H; Ofek I; Cohen S; Fridkin M
    Adv Exp Med Biol; 2000; 479():219-22. PubMed ID: 10897422
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationships of bacterial outer-membrane permeabilizers based on polymyxin B heptapeptides.
    Urakawa H; Yamada K; Komagoe K; Ando S; Oku H; Katsu T; Matsuo I
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1771-5. PubMed ID: 20138759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiological Assessment of Polymyxin B Components Tested Alone and in Combination.
    Kassamali Z; Prince RA; Danziger LH; Rotschafer JC; Rhomberg PR; Jones RN
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7823-5. PubMed ID: 26392511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide.
    Tsubery H; Ofek I; Cohen S; Fridkin M
    Biochemistry; 2000 Oct; 39(39):11837-44. PubMed ID: 11009595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria.
    Tsubery H; Ofek I; Cohen S; Fridkin M
    J Med Chem; 2000 Aug; 43(16):3085-92. PubMed ID: 10956216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mimicking an antimicrobial peptide polymyxin B by use of cyclodextrin.
    Yamamura H; Suzuki K; Uchibori K; Miyagawa A; Kawai M; Ohmizo C; Katsu T
    Chem Commun (Camb); 2012 Jan; 48(6):892-4. PubMed ID: 22143262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct modifications of the cyclic peptide Polymyxin B leading to analogues with enhanced in vitro antibacterial activity.
    Brown P; Abdulle O; Boakes S; Duperchy E; Moss S; Simonovic M; Stanway S; Wilson A; Dawson MJ
    Bioorg Med Chem Lett; 2020 Jun; 30(11):127163. PubMed ID: 32273214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antibacterial activity of peptide dendrimers and polymyxin B increases sharply above pH 7.4.
    Cai X; Javor S; Gan BH; Köhler T; Reymond JL
    Chem Commun (Camb); 2021 Jun; 57(46):5654-5657. PubMed ID: 33972964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Permeabilizing effects of sub-inhibitory concentrations of microcystin on the growth of Escherichia coli.
    Dixon RA; Al-Nazawi M; Alderson G
    FEMS Microbiol Lett; 2004 Jan; 230(2):167-70. PubMed ID: 14757235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria.
    Tsubery H; Yaakov H; Cohen S; Giterman T; Matityahou A; Fridkin M; Ofek I
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3122-8. PubMed ID: 16048913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity and Predicted Nephrotoxicity of Synthetic Antibiotics Based on Polymyxin B.
    Gallardo-Godoy A; Muldoon C; Becker B; Elliott AG; Lash LH; Huang JX; Butler MS; Pelingon R; Kavanagh AM; Ramu S; Phetsang W; Blaskovich MA; Cooper MA
    J Med Chem; 2016 Feb; 59(3):1068-77. PubMed ID: 26734854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity.
    Tsubery H; Ofek I; Cohen S; Fridkin M
    Peptides; 2001 Oct; 22(10):1675-81. PubMed ID: 11587796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the penetration of antimicrobial polymyxin lipopeptides into gram-negative bacteria.
    Deris ZZ; Swarbrick JD; Roberts KD; Azad MA; Akter J; Horne AS; Nation RL; Rogers KL; Thompson PE; Velkov T; Li J
    Bioconjug Chem; 2014 Apr; 25(4):750-60. PubMed ID: 24635310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of lipid A derivatives and their interactions with polymyxin B and polymyxin B nonapeptide.
    Yin N; Marshall RL; Matheson S; Savage PB
    J Am Chem Soc; 2003 Mar; 125(9):2426-35. PubMed ID: 12603130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization.
    Tsubery H; Ofek I; Cohen S; Eisenstein M; Fridkin M
    Mol Pharmacol; 2002 Nov; 62(5):1036-42. PubMed ID: 12391265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyxin B octapeptide and polymyxin B heptapeptide are potent outer membrane permeability-increasing agents.
    Kimura Y; Matsunaga H; Vaara M
    J Antibiot (Tokyo); 1992 May; 45(5):742-9. PubMed ID: 1624376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae.
    Pankey GA; Ashcraft DS
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):561-4. PubMed ID: 21767715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.
    Bratu S; Tolaney P; Karumudi U; Quale J; Mooty M; Nichani S; Landman D
    J Antimicrob Chemother; 2005 Jul; 56(1):128-32. PubMed ID: 15917285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of polymyxin B nonapeptide on daptomycin permeability and cell surface properties in Pseudomonas aeruginosa, Escherichia coli, and Pasteurella multocida.
    Morris CM; George A; Wilson WW; Champlin FR
    J Antibiot (Tokyo); 1995 Jan; 48(1):67-72. PubMed ID: 7868392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equal, but different: Fluctuant biofilm formation and its impact on polymyxin B susceptibility among a clonal spreading of KPC-2-producing Klebsiella pneumoniae isolates.
    Perez LRR
    Infect Control Hosp Epidemiol; 2019 Aug; 40(8):954-955. PubMed ID: 31106716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.